U.O Anestesia and Rianimazione Pediatrica, IRCCS Fondazione Ca' Granda Ospedale Maggiore, Policlinico di Milano , Milano , Italy.
Curr Med Res Opin. 2013 Dec;29(12):1685-90. doi: 10.1185/03007995.2013.835256. Epub 2013 Sep 13.
The aim of this randomized, patient-blinded study was to compare efficacy and safety of oral paracetamol plus intra-venous (i.v.) ketorolac with i.v. ketorolac alone after ambulatory uterine evacuation.
Women were randomly assigned to receive either oral paracetamol (1 g), in a melt-in-the mouth, without-water formulation plus ketorolac (30 mg i.v. once daily (o.d.)) or ketorolac (30 mg i.v. o.d.) as monotherapy. The mean duration of uterine evacuation was 11 minutes in the paracetamol + ketorolac group and 13 minutes in the ketorolac-only group. Paracetamol was administered 15 minutes before surgery, on discharge from hospital (mean 6 hours after surgery) and in the morning the day after surgery, while ketorolac was administered at the end of the surgical intervention.
The numeric rating scale (NRS) was used by patients to rate their pain on an 11 point scale.
Overall, 60 women received paracetamol plus ketorolac (group 1) and 60 ketorolac alone (group 2). There were significant differences in pain levels (NRS 0.92 and 2.08; p < 0.01) at T0 (when patients left the operating room 30 minutes after the end of surgery). At T1 (before discharge from hospital but before the next administration of paracetamol) there were no significant differences between NRS scores in the two groups (3.7 vs. 3.5, respectively, p = 0.3453). At T2 (in the morning after surgery; data collected by phone interview), following administration of the next dose of paracetamol, significant differences in pain scores were recorded (1.58 vs. 1.98; p = 0.01). Only a case of dizziness was reported in the paracetamol + ketorolac group, and no other unexpected adverse events were recorded.
Despite the small sample size and the monocentric nature of the study being taken into account, this study suggests, for the first time to our knowledge, that oral paracetamol t.i.d. in combination with i.v. ketorolac o.d. is effective and well tolerated in the control of postoperative pain after ambulatory uterine evacuation.
本随机、患者盲法研究旨在比较口服扑热息痛加静脉(i.v.)酮洛酸与单独静脉酮洛酸在门诊子宫排空后的疗效和安全性。
将患者随机分配接受口服扑热息痛(1 克),即口溶片,无需用水配方加酮洛酸(30 毫克 i.v. 每日一次(o.d.))或酮洛酸(30 毫克 i.v. o.d.)作为单药治疗。扑热息痛在手术前 15 分钟、出院时(平均术后 6 小时)和术后第二天早上给予,而酮洛酸在手术结束时给予。
患者使用数字评分量表(NRS)在 11 点量表上对疼痛进行评分。
共有 60 名女性接受了扑热息痛加酮洛酸(第 1 组)和 60 名单独接受酮洛酸(第 2 组)。两组患者在 T0 时(手术后 30 分钟离开手术室时)疼痛水平存在显著差异(NRS 0.92 和 2.08;p < 0.01)。在 T1 时(出院前但在下次扑热息痛给药前),两组 NRS 评分无显著差异(分别为 3.7 和 3.5,p = 0.3453)。在 T2 时(手术后早上;通过电话访谈收集数据),在给予下一次扑热息痛剂量后,记录到疼痛评分有显著差异(1.58 与 1.98;p = 0.01)。仅在扑热息痛加酮洛酸组报告了 1 例头晕病例,未记录到其他意外不良事件。
尽管考虑到样本量小和研究的单中心性质,但本研究首次表明,在门诊子宫排空后,口服扑热息痛 tid 联合静脉酮洛酸 od 控制术后疼痛是有效且耐受良好的。